Phase II open-label study to investigate PTK787/ZK 222584 (PTK/ZK) orally administered as a second-line monotherapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC)

ISSN
1556-0864
Date Issued
2007
Author(s)
Gauler, Thomas C.
Besse, Benjamin
Meric, J. B.
Gounant, Valerie
Fischer, B.
Krissel, Heiko
Laurent, Dirk
Soria, Jean-Charles
Eberhardt, Wilfried E.
DOI
10.1097/01.JTO.0000283188.24297.13